Editorial: Insights in experimental pharmacology and drug discovery: 2022
Resumen:
The aim set for this Research Topic was to continue providing a platform where researchers from around the world can describe new advances in the pharmacological field, and update the current state of scientific knowledge in areas related to pharmacological and therapeutic developments in human diseases. Following the Research Topic of 2022 (Trostchansky and Salomone, 2022), which focused on the use of various natural compounds with potential pharmacological effects, the authors contributing to this edition describe advancements in Therapeutic Approaches for Cancer Treatment, Chronic Pain Management, and Hormone-Dependent Diseases. In this context, the Research Topic comprises 4 articles, out of which two are original research articles, and the other two are literature reviews.
| 2023 | |
|
Experimental pharmacology Drug discovery Cancer Pain-drug therapy Tetrahydrobiopterin—BH4 Neuroinflammation FARMACOLOGÍA DESARROLLO EXPERIMENTAL NEOPLASIAS ENFERMEDADES NEUROINFLAMATORIAS QUIMIOTERAPIA FeENILCETONURIAS DESCUBRIMIENTO DE DROGAS |
|
| Inglés | |
| Universidad de la República | |
| COLIBRI | |
| https://hdl.handle.net/20.500.12008/53193 | |
| Acceso abierto | |
| Licencia Creative Commons Atribución (CC - By 4.0) |
| _version_ | 1872865100728107008 |
|---|---|
| author | Latini, Alexandra |
| author2 | Peralta Uroz, Carmen Trostchansky, Andrés |
| author2_role | author author |
| author_facet | Latini, Alexandra Peralta Uroz, Carmen Trostchansky, Andrés |
| author_role | author |
| bitstream.checksum.fl_str_mv | 6429389a7df7277b72b7924fdc7d47a9 a0ebbeafb9d2ec7cbb19d7137ebc392c a75c9caea9c1e5580e4349fed836d12c e7132498e7c1fe99f7096667baa99b25 7d4e6b0d22079e7293c4f207db560cbf |
| bitstream.checksumAlgorithm.fl_str_mv | MD5 MD5 MD5 MD5 MD5 |
| bitstream.url.fl_str_mv | http://localhost:8080/xmlui/bitstream/20.500.12008/53193/5/license.txt http://localhost:8080/xmlui/bitstream/20.500.12008/53193/2/license_url http://localhost:8080/xmlui/bitstream/20.500.12008/53193/3/license_text http://localhost:8080/xmlui/bitstream/20.500.12008/53193/4/license_rdf http://localhost:8080/xmlui/bitstream/20.500.12008/53193/1/Insights+in+experimental+pharmacology+and+drug+discovery.pdf |
| collection | COLIBRI |
| dc.contributor.filiacion.none.fl_str_mv | Latini Alexandra, Universidade Federal de Santa Catarina (Brasil). Biochemistry Department Peralta Uroz Carmen, August Pi i Sunyer Biomedical Research Institute (España) Trostchansky Andrés, Universidad de la República (Uruguay). Facultad de Medicina. Unidad Académica de Bioquímica |
| dc.coverage.temporal.es.fl_str_mv | 2022 |
| dc.creator.none.fl_str_mv | Latini, Alexandra Peralta Uroz, Carmen Trostchansky, Andrés |
| dc.date.accessioned.none.fl_str_mv | 2026-01-02T17:37:05Z |
| dc.date.available.none.fl_str_mv | 2026-01-02T17:37:05Z |
| dc.date.issued.none.fl_str_mv | 2023 |
| dc.description.abstract.none.fl_txt_mv | The aim set for this Research Topic was to continue providing a platform where researchers from around the world can describe new advances in the pharmacological field, and update the current state of scientific knowledge in areas related to pharmacological and therapeutic developments in human diseases. Following the Research Topic of 2022 (Trostchansky and Salomone, 2022), which focused on the use of various natural compounds with potential pharmacological effects, the authors contributing to this edition describe advancements in Therapeutic Approaches for Cancer Treatment, Chronic Pain Management, and Hormone-Dependent Diseases. In this context, the Research Topic comprises 4 articles, out of which two are original research articles, and the other two are literature reviews. |
| dc.format.extent.es.fl_str_mv | 2 p. |
| dc.format.mimetype.es.fl_str_mv | application/pdf |
| dc.identifier.citation.es.fl_str_mv | Latini A, Peralta Uroz C y Trostchansky A. Editorial: Insights in experimental pharmacology and drug discovery: 2022. Frontiers in Pharmacology [en línea]. 2023;14. 2 p. |
| dc.identifier.doi.none.fl_str_mv | 10.3389/fphar.2023.1250936 |
| dc.identifier.issn.none.fl_str_mv | 1663-9812 |
| dc.identifier.uri.none.fl_str_mv | https://hdl.handle.net/20.500.12008/53193 |
| dc.language.iso.none.fl_str_mv | en eng |
| dc.publisher.es.fl_str_mv | Frontiers |
| dc.relation.none.fl_str_mv | Frontiers in Pharmacology, 2023;14 |
| dc.rights.license.none.fl_str_mv | Licencia Creative Commons Atribución (CC - By 4.0) |
| dc.rights.none.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.source.none.fl_str_mv | reponame:COLIBRI instname:Universidad de la República instacron:Universidad de la República |
| dc.subject.es.fl_str_mv | Experimental pharmacology Drug discovery Cancer Pain-drug therapy Tetrahydrobiopterin—BH4 Neuroinflammation |
| dc.subject.other.es.fl_str_mv | FARMACOLOGÍA DESARROLLO EXPERIMENTAL NEOPLASIAS ENFERMEDADES NEUROINFLAMATORIAS QUIMIOTERAPIA FeENILCETONURIAS DESCUBRIMIENTO DE DROGAS |
| dc.title.none.fl_str_mv | Editorial: Insights in experimental pharmacology and drug discovery: 2022 |
| dc.type.es.fl_str_mv | Artículo |
| dc.type.none.fl_str_mv | info:eu-repo/semantics/article |
| dc.type.version.none.fl_str_mv | info:eu-repo/semantics/publishedVersion |
| description | The aim set for this Research Topic was to continue providing a platform where researchers from around the world can describe new advances in the pharmacological field, and update the current state of scientific knowledge in areas related to pharmacological and therapeutic developments in human diseases. Following the Research Topic of 2022 (Trostchansky and Salomone, 2022), which focused on the use of various natural compounds with potential pharmacological effects, the authors contributing to this edition describe advancements in Therapeutic Approaches for Cancer Treatment, Chronic Pain Management, and Hormone-Dependent Diseases. In this context, the Research Topic comprises 4 articles, out of which two are original research articles, and the other two are literature reviews. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | COLIBRI_9932a517720006dc18eadac76a145e49 |
| identifier_str_mv | Latini A, Peralta Uroz C y Trostchansky A. Editorial: Insights in experimental pharmacology and drug discovery: 2022. Frontiers in Pharmacology [en línea]. 2023;14. 2 p. 1663-9812 10.3389/fphar.2023.1250936 |
| instacron_str | Universidad de la República |
| institution | Universidad de la República |
| instname_str | Universidad de la República |
| language | eng |
| language_invalid_str_mv | en |
| network_acronym_str | COLIBRI |
| network_name_str | COLIBRI |
| oai_identifier_str | oai:colibri.udelar.edu.uy:20.500.12008/53193 |
| publishDate | 2023 |
| reponame_str | COLIBRI |
| repository.mail.fl_str_mv | karina.camps@seciu.edu.uy |
| repository.name.fl_str_mv | COLIBRI - Universidad de la República |
| repository_id_str | 4771 |
| rights_invalid_str_mv | Licencia Creative Commons Atribución (CC - By 4.0) |
| spelling | Latini Alexandra, Universidade Federal de Santa Catarina (Brasil). Biochemistry DepartmentPeralta Uroz Carmen, August Pi i Sunyer Biomedical Research Institute (España)Trostchansky Andrés, Universidad de la República (Uruguay). Facultad de Medicina. Unidad Académica de Bioquímica20222026-01-02T17:37:05Z2026-01-02T17:37:05Z2023Latini A, Peralta Uroz C y Trostchansky A. Editorial: Insights in experimental pharmacology and drug discovery: 2022. Frontiers in Pharmacology [en línea]. 2023;14. 2 p.1663-9812https://hdl.handle.net/20.500.12008/5319310.3389/fphar.2023.1250936The aim set for this Research Topic was to continue providing a platform where researchers from around the world can describe new advances in the pharmacological field, and update the current state of scientific knowledge in areas related to pharmacological and therapeutic developments in human diseases. Following the Research Topic of 2022 (Trostchansky and Salomone, 2022), which focused on the use of various natural compounds with potential pharmacological effects, the authors contributing to this edition describe advancements in Therapeutic Approaches for Cancer Treatment, Chronic Pain Management, and Hormone-Dependent Diseases. In this context, the Research Topic comprises 4 articles, out of which two are original research articles, and the other two are literature reviews.Submitted by Almiñana María Cecilia (marialminana@gmail.com) on 2025-12-30T13:31:16Z No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Insights in experimental pharmacology and drug discovery.pdf: 561813 bytes, checksum: 7d4e6b0d22079e7293c4f207db560cbf (MD5)Approved for entry into archive by Almiñana María Cecilia (marialminana@gmail.com) on 2026-01-02T17:25:57Z (GMT) No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Insights in experimental pharmacology and drug discovery.pdf: 561813 bytes, checksum: 7d4e6b0d22079e7293c4f207db560cbf (MD5)Made available in DSpace by Luna Fabiana (fabiana.luna@seciu.edu.uy) on 2026-01-02T17:37:05Z (GMT). No. of bitstreams: 2 license_rdf: 25630 bytes, checksum: e7132498e7c1fe99f7096667baa99b25 (MD5) Insights in experimental pharmacology and drug discovery.pdf: 561813 bytes, checksum: 7d4e6b0d22079e7293c4f207db560cbf (MD5) Previous issue date: 20232 p.application/pdfenengFrontiersFrontiers in Pharmacology, 2023;14Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)info:eu-repo/semantics/openAccessLicencia Creative Commons Atribución (CC - By 4.0)Experimental pharmacologyDrug discoveryCancerPain-drug therapyTetrahydrobiopterin—BH4NeuroinflammationFARMACOLOGÍADESARROLLO EXPERIMENTALNEOPLASIASENFERMEDADES NEUROINFLAMATORIASQUIMIOTERAPIAFeENILCETONURIASDESCUBRIMIENTO DE DROGASEditorial: Insights in experimental pharmacology and drug discovery: 2022Artículoinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:COLIBRIinstname:Universidad de la Repúblicainstacron:Universidad de la RepúblicaLatini, AlexandraPeralta Uroz, CarmenTrostchansky, AndrésLICENSElicense.txtlicense.txttext/plain; charset=utf-84267http://localhost:8080/xmlui/bitstream/20.500.12008/53193/5/license.txt6429389a7df7277b72b7924fdc7d47a9MD55CC-LICENSElicense_urllicense_urltext/plain; charset=utf-844http://localhost:8080/xmlui/bitstream/20.500.12008/53193/2/license_urla0ebbeafb9d2ec7cbb19d7137ebc392cMD52license_textlicense_texttext/html; charset=utf-835267http://localhost:8080/xmlui/bitstream/20.500.12008/53193/3/license_texta75c9caea9c1e5580e4349fed836d12cMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-825630http://localhost:8080/xmlui/bitstream/20.500.12008/53193/4/license_rdfe7132498e7c1fe99f7096667baa99b25MD54ORIGINALInsights in experimental pharmacology and drug discovery.pdfInsights in experimental pharmacology and drug discovery.pdfapplication/pdf561813http://localhost:8080/xmlui/bitstream/20.500.12008/53193/1/Insights+in+experimental+pharmacology+and+drug+discovery.pdf7d4e6b0d22079e7293c4f207db560cbfMD5120.500.12008/531932026-01-02 14:37:05.64oai:colibri.udelar.edu.uy:20.500.12008/53193VGVybWlub3MgeSBjb25kaWNpb25lcyByZWxhdGl2YXMgYWwgZGVwb3NpdG8gZGUgb2JyYXMKCgpMYXMgb2JyYXMgZGVwb3NpdGFkYXMgZW4gZWwgUmVwb3NpdG9yaW8gc2UgcmlnZW4gcG9yIGxhIE9yZGVuYW56YSBkZSBsb3MgRGVyZWNob3MgZGUgbGEgUHJvcGllZGFkIEludGVsZWN0dWFsICBkZSBsYSBVbml2ZXJzaWRhZCBEZSBMYSBSZXDDumJsaWNhLiAoUmVzLiBOwrogOTEgZGUgQy5ELkMuIGRlIDgvSUlJLzE5OTQg4oCTIEQuTy4gNy9JVi8xOTk0KSB5ICBwb3IgbGEgT3JkZW5hbnphIGRlbCBSZXBvc2l0b3JpbyBBYmllcnRvIGRlIGxhIFVuaXZlcnNpZGFkIGRlIGxhIFJlcMO6YmxpY2EgKFJlcy4gTsK6IDE2IGRlIEMuRC5DLiBkZSAwNy8xMC8yMDE0KS4gCgpBY2VwdGFuZG8gZWwgYXV0b3IgZXN0b3MgdMOpcm1pbm9zIHkgY29uZGljaW9uZXMgZGUgZGVww7NzaXRvIGVuIENPTElCUkksIGxhIFVuaXZlcnNpZGFkIGRlIFJlcMO6YmxpY2EgcHJvY2VkZXLDoSBhOiAgCgphKSBhcmNoaXZhciBtw6FzIGRlIHVuYSBjb3BpYSBkZSBsYSBvYnJhIGVuIGxvcyBzZXJ2aWRvcmVzIGRlIGxhIFVuaXZlcnNpZGFkIGEgbG9zIGVmZWN0b3MgZGUgZ2FyYW50aXphciBhY2Nlc28sIHNlZ3VyaWRhZCB5IHByZXNlcnZhY2nDs24KYikgY29udmVydGlyIGxhIG9icmEgYSBvdHJvcyBmb3JtYXRvcyBzaSBmdWVyYSBuZWNlc2FyaW8gIHBhcmEgZmFjaWxpdGFyIHN1IHByZXNlcnZhY2nDs24geSBhY2Nlc2liaWxpZGFkIHNpbiBhbHRlcmFyIHN1IGNvbnRlbmlkby4KYykgcmVhbGl6YXIgbGEgY29tdW5pY2FjacOzbiBww7pibGljYSB5IGRpc3BvbmVyIGVsIGFjY2VzbyBsaWJyZSB5IGdyYXR1aXRvIGEgdHJhdsOpcyBkZSBJbnRlcm5ldCBtZWRpYW50ZSBsYSBwdWJsaWNhY2nDs24gZGUgbGEgb2JyYSBiYWpvIGxhIGxpY2VuY2lhIENyZWF0aXZlIENvbW1vbnMgc2VsZWNjaW9uYWRhIHBvciBlbCBwcm9waW8gYXV0b3IuCgoKRW4gY2FzbyBxdWUgZWwgYXV0b3IgaGF5YSBkaWZ1bmRpZG8geSBkYWRvIGEgcHVibGljaWRhZCBhIGxhIG9icmEgZW4gZm9ybWEgcHJldmlhLCAgcG9kcsOhIHNvbGljaXRhciB1biBwZXLDrW9kbyBkZSBlbWJhcmdvIHNvYnJlIGxhIGRpc3BvbmliaWxpZGFkIHDDumJsaWNhIGRlIGxhIG1pc21hLCBlbCBjdWFsIGNvbWVuemFyw6EgYSBwYXJ0aXIgZGUgbGEgYWNlcHRhY2nDs24gZGUgZXN0ZSBkb2N1bWVudG8geSBoYXN0YSBsYSBmZWNoYSBxdWUgaW5kaXF1ZSAuCgpFbCBhdXRvciBhc2VndXJhIHF1ZSBsYSBvYnJhIG5vIGluZnJpZ2UgbmluZ8O6biBkZXJlY2hvIHNvYnJlIHRlcmNlcm9zLCB5YSBzZWEgZGUgcHJvcGllZGFkIGludGVsZWN0dWFsIG8gY3VhbHF1aWVyIG90cm8uCgpFbCBhdXRvciBnYXJhbnRpemEgcXVlIHNpIGVsIGRvY3VtZW50byBjb250aWVuZSBtYXRlcmlhbGVzIGRlIGxvcyBjdWFsZXMgbm8gdGllbmUgbG9zIGRlcmVjaG9zIGRlIGF1dG9yLCAgaGEgb2J0ZW5pZG8gZWwgcGVybWlzbyBkZWwgcHJvcGlldGFyaW8gZGUgbG9zIGRlcmVjaG9zIGRlIGF1dG9yLCB5IHF1ZSBlc2UgbWF0ZXJpYWwgY3V5b3MgZGVyZWNob3Mgc29uIGRlIHRlcmNlcm9zIGVzdMOhIGNsYXJhbWVudGUgaWRlbnRpZmljYWRvIHkgcmVjb25vY2lkbyBlbiBlbCB0ZXh0byBvIGNvbnRlbmlkbyBkZWwgZG9jdW1lbnRvIGRlcG9zaXRhZG8gZW4gZWwgUmVwb3NpdG9yaW8uCgpFbiBvYnJhcyBkZSBhdXRvcsOtYSBtw7psdGlwbGUgL3NlIHByZXN1bWUvIHF1ZSBlbCBhdXRvciBkZXBvc2l0YW50ZSBkZWNsYXJhIHF1ZSBoYSByZWNhYmFkbyBlbCBjb25zZW50aW1pZW50byBkZSB0b2RvcyBsb3MgYXV0b3JlcyBwYXJhIHB1YmxpY2FybGEgZW4gZWwgUmVwb3NpdG9yaW8sIHNpZW5kbyDDqXN0ZSBlbCDDum5pY28gcmVzcG9uc2FibGUgZnJlbnRlIGEgY3VhbHF1aWVyIHRpcG8gZGUgcmVjbGFtYWNpw7NuIGRlIGxvcyBvdHJvcyBjb2F1dG9yZXMuCgpFbCBhdXRvciBzZXLDoSByZXNwb25zYWJsZSBkZWwgY29udGVuaWRvIGRlIGxvcyBkb2N1bWVudG9zIHF1ZSBkZXBvc2l0YS4gTGEgVURFTEFSIG5vIHNlcsOhIHJlc3BvbnNhYmxlIHBvciBsYXMgZXZlbnR1YWxlcyB2aW9sYWNpb25lcyBhbCBkZXJlY2hvIGRlIHByb3BpZWRhZCBpbnRlbGVjdHVhbCBlbiBxdWUgcHVlZGEgaW5jdXJyaXIgZWwgYXV0b3IuCgpBbnRlIGN1YWxxdWllciBkZW51bmNpYSBkZSB2aW9sYWNpw7NuIGRlIGRlcmVjaG9zIGRlIHByb3BpZWRhZCBpbnRlbGVjdHVhbCwgbGEgVURFTEFSICBhZG9wdGFyw6EgdG9kYXMgbGFzIG1lZGlkYXMgbmVjZXNhcmlhcyBwYXJhIGV2aXRhciBsYSBjb250aW51YWNpw7NuIGRlIGRpY2hhIGluZnJhY2Npw7NuLCBsYXMgcXVlIHBvZHLDoW4gaW5jbHVpciBlbCByZXRpcm8gZGVsIGFjY2VzbyBhIGxvcyBjb250ZW5pZG9zIHkvbyBtZXRhZGF0b3MgZGVsIGRvY3VtZW50byByZXNwZWN0aXZvLgoKTGEgb2JyYSBzZSBwb25kcsOhIGEgZGlzcG9zaWNpw7NuIGRlbCBww7pibGljbyBhIHRyYXbDqXMgZGUgbGFzIGxpY2VuY2lhcyBDcmVhdGl2ZSBDb21tb25zLCBlbCBhdXRvciBwb2Ryw6Egc2VsZWNjaW9uYXIgdW5hIGRlIGxhcyA2IGxpY2VuY2lhcyBkaXNwb25pYmxlczoKCgpBdHJpYnVjacOzbiAoQ0MgLSBCeSk6IFBlcm1pdGUgdXNhciBsYSBvYnJhIHkgZ2VuZXJhciBvYnJhcyBkZXJpdmFkYXMsIGluY2x1c28gY29uIGZpbmVzIGNvbWVyY2lhbGVzLCBzaWVtcHJlIHF1ZSBzZSByZWNvbm96Y2EgYWwgYXV0b3IuCgpBdHJpYnVjacOzbiDigJMgQ29tcGFydGlyIElndWFsIChDQyAtIEJ5LVNBKTogUGVybWl0ZSB1c2FyIGxhIG9icmEgeSBnZW5lcmFyIG9icmFzIGRlcml2YWRhcywgaW5jbHVzbyBjb24gZmluZXMgY29tZXJjaWFsZXMsIHBlcm8gbGEgZGlzdHJpYnVjacOzbiBkZSBsYXMgb2JyYXMgZGVyaXZhZGFzIGRlYmUgaGFjZXJzZSBtZWRpYW50ZSB1bmEgbGljZW5jaWEgaWTDqW50aWNhIGEgbGEgZGUgbGEgb2JyYSBvcmlnaW5hbCwgcmVjb25vY2llbmRvIGEgbG9zIGF1dG9yZXMuCgpBdHJpYnVjacOzbiDigJMgTm8gQ29tZXJjaWFsIChDQyAtIEJ5LU5DKTogUGVybWl0ZSB1c2FyIGxhIG9icmEgeSBnZW5lcmFyIG9icmFzIGRlcml2YWRhcywgc2llbXByZSB5IGN1YW5kbyBlc29zIHVzb3Mgbm8gdGVuZ2FuIGZpbmVzIGNvbWVyY2lhbGVzLCByZWNvbm9jaWVuZG8gYWwgYXV0b3IuCgpBdHJpYnVjacOzbiDigJMgU2luIERlcml2YWRhcyAoQ0MgLSBCeS1ORCk6IFBlcm1pdGUgZWwgdXNvIGRlIGxhIG9icmEsIGluY2x1c28gY29uIGZpbmVzIGNvbWVyY2lhbGVzLCBwZXJvIG5vIHNlIHBlcm1pdGUgZ2VuZXJhciBvYnJhcyBkZXJpdmFkYXMsIGRlYmllbmRvIHJlY29ub2NlciBhbCBhdXRvci4KCkF0cmlidWNpw7NuIOKAkyBObyBDb21lcmNpYWwg4oCTIENvbXBhcnRpciBJZ3VhbCAoQ0Mg4oCTIEJ5LU5DLVNBKTogUGVybWl0ZSB1c2FyIGxhIG9icmEgeSBnZW5lcmFyIG9icmFzIGRlcml2YWRhcywgc2llbXByZSB5IGN1YW5kbyBlc29zIHVzb3Mgbm8gdGVuZ2FuIGZpbmVzIGNvbWVyY2lhbGVzIHkgbGEgZGlzdHJpYnVjacOzbiBkZSBsYXMgb2JyYXMgZGVyaXZhZGFzIHNlIGhhZ2EgbWVkaWFudGUgbGljZW5jaWEgaWTDqW50aWNhIGEgbGEgZGUgbGEgb2JyYSBvcmlnaW5hbCwgcmVjb25vY2llbmRvIGEgbG9zIGF1dG9yZXMuCgpBdHJpYnVjacOzbiDigJMgTm8gQ29tZXJjaWFsIOKAkyBTaW4gRGVyaXZhZGFzIChDQyAtIEJ5LU5DLU5EKTogUGVybWl0ZSB1c2FyIGxhIG9icmEsIHBlcm8gbm8gc2UgcGVybWl0ZSBnZW5lcmFyIG9icmFzIGRlcml2YWRhcyB5IG5vIHNlIHBlcm1pdGUgdXNvIGNvbiBmaW5lcyBjb21lcmNpYWxlcywgZGViaWVuZG8gcmVjb25vY2VyIGFsIGF1dG9yLgoKTG9zIHVzb3MgcHJldmlzdG9zIGVuIGxhcyBsaWNlbmNpYXMgaW5jbHV5ZW4gbGEgZW5hamVuYWNpw7NuLCByZXByb2R1Y2Npw7NuLCBjb211bmljYWNpw7NuLCBwdWJsaWNhY2nDs24sIGRpc3RyaWJ1Y2nDs24geSBwdWVzdGEgYSBkaXNwb3NpY2nDs24gZGVsIHDDumJsaWNvLiBMYSBjcmVhY2nDs24gZGUgb2JyYXMgZGVyaXZhZGFzIGluY2x1eWUgbGEgYWRhcHRhY2nDs24sIHRyYWR1Y2Npw7NuIHkgZWwgcmVtaXguCgpDdWFuZG8gc2Ugc2VsZWNjaW9uZSB1bmEgbGljZW5jaWEgcXVlIGhhYmlsaXRlIHVzb3MgY29tZXJjaWFsZXMsIGVsIGRlcMOzc2l0byBkZWJlcsOhIHNlciBhY29tcGHDsWFkbyBkZWwgYXZhbCBkZWwgamVyYXJjYSBtw6F4aW1vIGRlbCBTZXJ2aWNpbyBjb3JyZXNwb25kaWVudGUuCg==Institucionalhttps://www.colibri.udelar.edu.uyUniversidad públicahttps://udelar.edu.uy/https://www.colibri.udelar.edu.uy/oai/requestkarina.camps@seciu.edu.uyUruguayopendoar:47712026-01-02T17:37:05COLIBRI - Universidad de la Repúblicafalse |
| spellingShingle | Editorial: Insights in experimental pharmacology and drug discovery: 2022 Latini, Alexandra Experimental pharmacology Drug discovery Cancer Pain-drug therapy Tetrahydrobiopterin—BH4 Neuroinflammation FARMACOLOGÍA DESARROLLO EXPERIMENTAL NEOPLASIAS ENFERMEDADES NEUROINFLAMATORIAS QUIMIOTERAPIA FeENILCETONURIAS DESCUBRIMIENTO DE DROGAS |
| status_str | publishedVersion |
| title | Editorial: Insights in experimental pharmacology and drug discovery: 2022 |
| title_full | Editorial: Insights in experimental pharmacology and drug discovery: 2022 |
| title_fullStr | Editorial: Insights in experimental pharmacology and drug discovery: 2022 |
| title_full_unstemmed | Editorial: Insights in experimental pharmacology and drug discovery: 2022 |
| title_short | Editorial: Insights in experimental pharmacology and drug discovery: 2022 |
| title_sort | Editorial: Insights in experimental pharmacology and drug discovery: 2022 |
| topic | Experimental pharmacology Drug discovery Cancer Pain-drug therapy Tetrahydrobiopterin—BH4 Neuroinflammation FARMACOLOGÍA DESARROLLO EXPERIMENTAL NEOPLASIAS ENFERMEDADES NEUROINFLAMATORIAS QUIMIOTERAPIA FeENILCETONURIAS DESCUBRIMIENTO DE DROGAS |
| url | https://hdl.handle.net/20.500.12008/53193 |
